| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | 448,0 k € | +30.5% | 343,2 k € | -3.0% | 353,8 k € | +10.3% | 320,8 k € | -0.7% | 323,0 k € | +0.8% | 320,5 k € | ||||||
| Gross margin | 202,1 k € | +37.3% | 147,2 k € | -3.7% | 152,9 k € | -4.2% | 159,6 k € | +87.0% | 85,3 k € | — | — | — | — | — | — | |||||||
| EBITDA | 109,3 k € | +153.3% | 43,1 k € | -30.2% | 61,8 k € | -16.6% | 74,1 k € | +263.2% | 20,4 k € | -36.0% | 31,9 k € | +263.0% | -19,5 k € | -299.2% | 9,8 k € | +132.8% | -29,9 k € | -149.9% | 60,0 k € | +5.4% | 57,0 k € | |
| Operating profit | 100,5 k € | +85.6% | 54,1 k € | -7.0% | 58,2 k € | -17.7% | 70,7 k € | +224.9% | 21,8 k € | -15.2% | 25,7 k € | +477.3% | 4,4 k € | +118.5% | -24,0 k € | +18.9% | -29,6 k € | -156.8% | 52,1 k € | -8.2% | 56,7 k € | |
| Profit/loss | 72,4 k € | +95.1% | 37,1 k € | -12.0% | 42,2 k € | -18.0% | 51,4 k € | +161.6% | 19,7 k € | -15.6% | 23,3 k € | +1997.4% | 1,1 k € | +103.3% | -33,2 k € | -9.0% | -30,5 k € | -206.9% | 28,5 k € | -27.0% | 39,1 k € | |
| Equity | 312,4 k € | +30.1% | 240,0 k € | +18.3% | 203,0 k € | +26.2% | 160,8 k € | +47.0% | 109,4 k € | +21.9% | 89,7 k € | +35.0% | 66,5 k € | +1.7% | 65,3 k € | -33.7% | 98,6 k € | -23.6% | 129,1 k € | +28.4% | 100,6 k € | |
| Total assets | 604,1 k € | +20.1% | 502,9 k € | +21.1% | 415,3 k € | +13.9% | 364,4 k € | +42.8% | 255,2 k € | +7.5% | 237,4 k € | +35.4% | 175,3 k € | +4.1% | 168,3 k € | -10.7% | 188,5 k € | -15.8% | 223,8 k € | +38.5% | 161,6 k € | |
| Cash | 42,0 k € | -13.5% | 48,6 k € | -44.7% | 87,8 k € | -20.3% | 110,1 k € | +88.2% | 58,5 k € | -28.3% | 81,7 k € | +43.2% | 57,0 k € | +212.8% | 18,2 k € | -31.1% | 26,5 k € | -61.9% | 69,4 k € | +264.4% | 19,0 k € | |
| Debts | 212,2 k € | +55.1% | 136,8 k € | +13.4% | 120,6 k € | +30.4% | 92,5 k € | +33.2% | 69,5 k € | +8.0% | 64,3 k € | -4.5% | 67,4 k € | -10.7% | 75,4 k € | -12.3% | 86,0 k € | -4.4% | 89,9 k € | +59.6% | 56,3 k € | |
| Staff | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1,3 | 1,8 | 1 | 1,1 | |||||||||||
Public limited company · Gent · incorporated on 16/01/2014 · 1,0 ETP
Public limited company profitable and well capitalised. Cash position declining (-13.5%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Biotech Dental Benelux is a Public limited company incorporated in 2014. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Gent. It employs on average 1,0 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.